Paper38461908
Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications.
Liu Y and 4 others. Eur J Pharmacol, 2024. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications. Papers, record 38461908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38461908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Reperfusion Injury | Major topic |
| Reperfusion Injury | Major topic |
| Humans | |
| Pyroptosis | |
| Inflammasomes | |
| Ischemia | |
| Reperfusion | |
| NLR Family, Pyrin Domain-Containing 3 Protein |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939749 | The DAMP Awakens: The Role of Heme and Heme Oxygenase-1 in Organ Transplantation. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939749 | PubMed |
| 42662069 | Decoding the molecular mechanisms of pyroptosis and its therapeutic development prospects. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42662069 | PubMed |
| 42534140 | Potential Relationship Between Ferroptosis and Pyroptosis in Myocardial Ischemia/Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets. | Rev Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42534140 | PubMed |
| 42517156 | Bibliometric Trends in Inflammasome‑Driven Pyroptosis and Cardiovascular Disease. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42517156 | PubMed |
| 42305535 | Electroacupuncture alleviates myocardial ischemia-reperfusion injury by targeting and inhibiting NLRP3 inflammasome-mediated cardiomyocyte pyroptosis via serum exosomal miR-22-3p. | Front Immunol | 2026 | https://conductscience.org/library/papers/42305535 | PubMed |
| 42004515 | Delta opioid peptide (D-Ala2, D-Leu5)-enkephalin (DADLE) mitigates myocardial ischemia-reperfusion injury by inhibiting the TRAF6/NF-κB/NLRP3 pathway. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42004515 | PubMed |
| 42004242 | Research Progress of Nerve Injury-Induced Protein 1 in Cardiovascular Diseases. | Cardiol Res Pract | 2026 | https://conductscience.org/library/papers/42004242 | PubMed |
| 41826966 | Salvigenin alleviates ferroptosis and pyroptosis in myocardial ischemia/reperfusion models by inhibiting the NLRP3 pathway. | Biomed Eng Online | 2026 | https://conductscience.org/library/papers/41826966 | PubMed |
| 41575474 | BMP7 attenuates myocardial injury and preserves cardiac function after myocardial infarction by inhibiting cardiomyocyte pyroptosis. | Apoptosis | 2026 | https://conductscience.org/library/papers/41575474 | PubMed |
| 41378869 | Mechanism of Hypoxia-Induced HMGB1 Regulating NLRP3 Inflammasome/Caspase-1 Pathway-Mediated Pyroptosis in Myocardial Ischemia Reperfusion Injury Through the Nrf2/HO-1 Pathway. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/41378869 | PubMed |
| 41252094 | Cell death forms in myocardial ischemia-reperfusion injury and their potential clinical applications. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41252094 | PubMed |
| 41160375 | Emerging Dual Roles of ALKBH5 in Ischemia-reperfusion Injury: Mechanisms and Therapeutic Implications. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41160375 | PubMed |
| 41113142 | Estrogen Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. | Cardiol Res Pract | 2025 | https://conductscience.org/library/papers/41113142 | PubMed |
| 40779176 | Butyrate protects against myocardial ischemia injury and cardiomyocyte pyroptosis by inhibiting MALT1-mediated Nrf2 ubiquitination and degradation. | J Mol Histol | 2025 | https://conductscience.org/library/papers/40779176 | PubMed |
| 40717825 | Sevoflurane Alleviates Cardiomyocyte Ferroptosis via Ubiquitin-Specific Protease 7/Phosphatase and Tensin Homolog Modulation. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/40717825 | PubMed |
| 40391625 | Salvia miltiorrhiza-derived exosome-like nanoparticles improve diabetic cardiomyopathy by inhibiting NLRP3 inflammasome-mediated macrophage pyroptosis via targeting the NEDD4/SGK1 axis. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40391625 | PubMed |
| 40227195 | Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40227195 | PubMed |
| 40094786 | A study on the molecular mechanism of cardiac protection of procarboxylpeptidase in MIRI rats based on the NLRP3 signaling pathway. | Sci Prog | 2025 | https://conductscience.org/library/papers/40094786 | PubMed |
| 39886966 | Remimazolam alleviates myocardial ischemia/reperfusion injury and inflammation via inhibition of the NLRP3/IL‑1β pathway in mice. | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39886966 | PubMed |
| 39575347 | Diltiazem Hydrochloride Protects Against Myocardial Ischemia/Reperfusion Injury in a BNIP3L/NIX-Mediated Mitophagy Manner. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39575347 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38461908
GET https://conductscience.org/api/papers/v1/38461908/cited_by?page=2